Sutro Biopharma, Inc. Profile Avatar - Palmy Investing

Sutro Biopharma, Inc.

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conj…

Biotechnology
US, South San Francisco [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Sutro Biopharma, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Sutro Biopharma, Inc. can't present revenue by segment

End of STRO's Analysis
CIK: 1382101 CUSIP: 869367102 ISIN: US8693671021 LEI: - UEI: -
Secondary Listings
STRO has no secondary listings inside our databases.